EP665 Juvenile granulosa cell tumors of the ovary: a retrospective study of 36 patients. (1st November 2019)
- Record Type:
- Journal Article
- Title:
- EP665 Juvenile granulosa cell tumors of the ovary: a retrospective study of 36 patients. (1st November 2019)
- Main Title:
- EP665 Juvenile granulosa cell tumors of the ovary: a retrospective study of 36 patients
- Authors:
- Blot-Dupin, M
Maulard, A
Genestie, C
Pautier, P
Bentivegna, E
Leary, A
Chargari, C
Morice, P
Gouy, S - Abstract:
- Abstract : Introduction/Background: Granulosa cell tumors account for approximatively 3% of ovarian tumors. The juvenile histological type (JGCT) represents 5% of them, and remains relatively unknown. Our aim was to describe clinicopathologic characteristics and to evaluate prognostic factors. Methodology: We retrospectively studied medical records of 40 patients referred to our center for JGCT between November 2010 and 2018. Results: Thirty-six patients had confirmed JGCT. The mean age was 19, 9 years (range 2, 5 months - 47, 4 years). Abdominal pain (53%), vaginal bleeding (31%), palpable mass (28%), were the most common presenting symptoms. The distribution of FIGO stage was: 16 patients at stage Ia, 17 Ic, 1 IIa, 1 IIIb, 1 IIIc. Thirty-two patients (89%) had conservative surgery. Sixteen (44%) received adjuvant chemotherapy (Ic=13, IIa=1, IIIb=1, IIIc=1), mostly bleomycine/etoposide/cisplatine regimen. The mean follow up was 35 months (range 1 to 204 months). Nine patients recurred (Ia=1, Ic=6, IIa=1, IIIc=1) with a mean time of 12, 1 months (range 1–47). Among them, 4 had a cystectomy at the initial surgery: 3 without adjuvant chemotherapy, 2 died of disease; 4 stage Ic did not received adjuvant chemotherapy neither. Three patients died after a mean of 21, 2 months (range 9, 5–32, 4). At 36 months: progression free survival was 70, 4% [54, 9–90, 2], overall survival was 85, 6% [71, 4–100]. The main prognosis factor of recurrence was advanced FIGO stage (p< 0, 001) . AgeAbstract : Introduction/Background: Granulosa cell tumors account for approximatively 3% of ovarian tumors. The juvenile histological type (JGCT) represents 5% of them, and remains relatively unknown. Our aim was to describe clinicopathologic characteristics and to evaluate prognostic factors. Methodology: We retrospectively studied medical records of 40 patients referred to our center for JGCT between November 2010 and 2018. Results: Thirty-six patients had confirmed JGCT. The mean age was 19, 9 years (range 2, 5 months - 47, 4 years). Abdominal pain (53%), vaginal bleeding (31%), palpable mass (28%), were the most common presenting symptoms. The distribution of FIGO stage was: 16 patients at stage Ia, 17 Ic, 1 IIa, 1 IIIb, 1 IIIc. Thirty-two patients (89%) had conservative surgery. Sixteen (44%) received adjuvant chemotherapy (Ic=13, IIa=1, IIIb=1, IIIc=1), mostly bleomycine/etoposide/cisplatine regimen. The mean follow up was 35 months (range 1 to 204 months). Nine patients recurred (Ia=1, Ic=6, IIa=1, IIIc=1) with a mean time of 12, 1 months (range 1–47). Among them, 4 had a cystectomy at the initial surgery: 3 without adjuvant chemotherapy, 2 died of disease; 4 stage Ic did not received adjuvant chemotherapy neither. Three patients died after a mean of 21, 2 months (range 9, 5–32, 4). At 36 months: progression free survival was 70, 4% [54, 9–90, 2], overall survival was 85, 6% [71, 4–100]. The main prognosis factor of recurrence was advanced FIGO stage (p< 0, 001) . Age >15 years (p= 0, 09) and cytonuclear atypia (p= 0, 08) tended to be associated to relapse too. Intra operative tumor rupture (p= 0, 03) was a significant risk factor of death.We observed 5 pregnancies with term deliveries. Conclusion: The main prognostic factors are: FIGO stage and intra operative tumor rupture. Fertility sparing surgery is safe for stage Ia, reasonable for stage Ic combined with adjuvant chemotherapy. Patients with cystectomy had poor outcome; unilateral salpingo-oophorectomy must be done sytematically. Disclosure: Nothing to disclose. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 29(2019)Supplement 4
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 29(2019)Supplement 4
- Issue Display:
- Volume 29, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 4
- Issue Sort Value:
- 2019-0029-0004-0000
- Page Start:
- A385
- Page End:
- A385
- Publication Date:
- 2019-11-01
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2019-ESGO.719 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19763.xml